Recommendations of GESIDA/Spanish National Plan of AIDS on diagnosis and treatment of Kaposi's sarcoma and cervical cancer in HIV-infected patients
Podzamczer, D.; Miralles, P.; La Calle Md, Mía.de.; Zarco, C.; Berenguer, J.; López Aldeguer, Jé.; Valencia, E.; Rubio, R.; Ribera, J-María.
Medicina Clinica 118(20): 788-795
2002
ISSN/ISBN: 0025-7753 PMID: 12049697 Document Number: 546754
Document emailed within 1 workday
Related Documents
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379Iribarren, J.A.; Ramos, J.T.; Guerra, L.; Coll, O.; de José, M.I.; Domingo, P.; Fortuny, C.; Miralles, P.; Parras, F.; Peña, J.M.; Rodrigo, C.; Vidal, R. 2001: Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society Enfermedades Infecciosas Y Microbiologia Clinica 19(7): 314-335
Betegón, L.; Cotarelo, M.; Vendrell, Bén. 2012: Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines Enfermedades infecciosas y microbiologia clinica 30(8): 508-9; author reply 511-2
Polo Rodríguez, R.; Amador Prous, Cón.; Deig Comerma, E.; Fumaz, C.R.; Galindo Puerto, M.José.; Koerting de Castro, A.; Merino Munoz, D.; Miralles Álvarez, C.; MunozGálligo, E.; Núnez Cuadros, E.; Ollé Rodríguez, C.; Pérez Elías, M.Jesús.; Valencia Ortega, E.; Gisbert Civera, I. 2014: Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA) Enfermedades infecciosas y microbiologia clinica 32(2): 100-105
Polo Rodríguez, R.; Amador Prous, Cón.; Deig Comerma, E.; Fumaz, C.R.; Galindo Puerto, M.José.; Koerting de Castro, A.; Merino Munoz, D.; Miralles Álvarez, C.; MunozGálligo, E.; Núnez Cuadros, E.; Ollé Rodríguez, C.; Pérez Elías, M.Jesús.; Valencia Ortega, E.; Gisbert Civera, I. 2014: Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA) Enfermedades infecciosas y microbiologia clinica 32(2): 100-105
Polo Rodríguez, R.; Amador Prous, Cón.; Deig Comerma, E.Deig.; Fumazd, C.R.; Galindo Puerto, M..José.; Koerting de Castro, A.; Merino Muñoz, D.; Miralles Álvarez, C.; Muñoz Gálligo, E.; Núñez Cuadros, E.; Ollé Rodríguez, C.; Pérez Elías, M..Jesús.; Valencia Ortega, E.; Gisbert Civera, I. 2014: Consensus statement on assistance to women with human immunodeficiency virus infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA) Enfermedades Infecciosas y Microbiologia Clinica 32(2): 99.E1-99.E14
Payne, S.F.; Lemp, G.F.; Rutherford, G.W. 1990: Survival following diagnosis of Kaposi's sarcoma for AIDS patients in San Francisco Journal of Acquired Immune Deficiency Syndromes 3(Suppl 1): S14-S17
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Haverkos, H.W.; Drotman, D.P. 1985: Prevalence of Kaposi's sarcoma among patients with AIDS New England Journal of Medicine 312(23): 1518
Müller, H.E. 1988: Viral etiology of Kaposi's sarcoma in AIDS patients? Deutsche Medizinische Wochenschrift 113(4): 157-158
Plettenberg, A.; Albrecht, D.; Lorenzen, T.; Meyer, T.; Arndt, R.; Stoehr, A. 2002: Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma European Journal of Medical Research 7(1): 19-24
Polo, R.; José Galindo, M.; Martínez, E.; Alvarez, J.; Arévalo, Jé.Manuel.; Asensi, Víctor.; Cánoves, D.; Cáncer, E.; Collazos, J.; Estrada, V.; Gómez-Candela, C.; Johnston, S.; Locutura, J.; López-Aldeguer, Jé.; Lozano, F.; Miralles, C.; Muñoz-Sanz, Aín.; Ortega, E.; Pascua, J.; Pedrol, E.; Pulido, F.; San Martín, M.; Sanz, Jús.; Viciana, P.; Chamorro, L. 2006: Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection Enfermedades Infecciosas y Microbiologia Clinica 24(2): 96-117
Félix, H.; Rozenbaum, W.; Karabinis, A.; Rosenheim, M.; Brucker, G.; Duflo, B.; Gentilini, M. 1984: Problems raised by the treatment of Kaposi's sarcoma in subjects with AIDS Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 77(4 Part 2): 592-598
Chandra, A.; Demirhan, I.; Massambu, C.; Pyakurel, P.; Kaaya, E.; Enbom, M.; Urassa, W.; Linde, A.; Heiden, T.; Biberfeld, P.; Doerr, H.W.; Cinatl, J.; Loewer, J.; Chandra, P. 2003: Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients Anticancer Research 23(1b): 723-728
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Ghyka, G.; Alecu, M.; Hălălău, F.; Călugăru, A.; Coman, G. 1991: Human leukocyte interferon treatment associated with IL-2 in the non-AIDS related Kaposi's sarcoma Romanian Journal of Internal Medicine 29(1-2): 75-83
Hsu, C.H.; Chen, M.Y.; Cheng, A.L. 2000: Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel Anticancer Research 20(2b): 1159-1161
Alecu, M.; Ghyka, G.; Hălălău, F.; Călugăru, A.; Coman, G. 1990: Intralesional human leukocyte interferon treatment in the non-AIDS related Kaposi's sarcoma Medecine Interne 28(1): 61-67
Dezube, B.J.; Pantanowitz, L.; Aboulafia, D.M. 2004: Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment Aids Reader 14(5): 236-8 243-4 251-3
Voltchek, I.V.; Liepins, A.; Nowicky, J.W.; Brzosko, W.J. 1996: Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma Drugs under Experimental and Clinical Research 22(3-5): 283-286